Shin Nippon Biomedical Laboratories : Conclusion of Memorandum of Understanding with Medgaea Life Sciences Ltd. for Cooperative Relationship
August 29, 2018 at 02:52 am EDT
Share
On August 3, 2018, at the Taiwan 2018 Latest Business Seminar in Tokyo, SNBL and Medgaea Life Sciences Ltd. (MDG) signed a Memorandum of Understanding (MOU). The MOU, signed by Dr. Chih-Chun Hong, Chief Executive Officer of MDG, andKoichiro Fukuzaki, Executive Vice Chairman of SNBL,confirms the intention of SNBL and MDGto collaborate more closely.
MDG was established in Taiwan in 2005 and offers a variety of pre-clinical contract research services for health foods, herbal medicine, medical devices, and chemical products. SNBL and MDG will promote and support R&D of drugs, medical devices, and regenerative medicine in Taiwan.
Attachments
Original document
Permalink
Disclaimer
Shin Nippon Biomedical Laboratories Ltd. published this content on 29 August 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 August 2018 06:51:03 UTC
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 
